CA

Chithirala Alekhya

Active Director Director DIN 11058321
DIN 11058321 First appointment Apr 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Chithirala Alekhya

Data last updated:

Chithirala Alekhya is a Director at Veenuz Medical Diagnostics Private Limited (since 2025).

DIN 11058321
Primary Designation Director
First Appointment 16 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20252025Active

Directorship timeline

Open interactive timeline →
Veenuz Medical Diagnostics Private Limited
Premium access

Shareholding and investment profile for Chithirala Alekhya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chithirala Alekhya

Chithirala Alekhya currently holds 1 directorship: Veenuz Medical Diagnostics Private Limited (Director, since 16 Apr 2025).

Chithirala Alekhya was first appointed on 16 Apr 2025 as Director at Veenuz Medical Diagnostics Private Limited.

The current boards of Chithirala Alekhya's companies include Lavanya Chinthalapudi (Veenuz Medical Diagnostics Private Limited), Praveena Derangula (Veenuz Medical Diagnostics Private Limited), Sreelakshmi Bharathala (Veenuz Medical Diagnostics Private Limited), Srinivasarao Gummadidala (Veenuz Medical Diagnostics Private Limited), Venkatesh Kumar Rachaputi (Veenuz Medical Diagnostics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available